Cargando…

ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma

BACKGROUND: Integrin α5 (ITGA5) was involved in a variety of cancers. However, the role of ITGA5 in laryngeal squamous cell carcinoma (LSCC) remains unknown. METHODS: The expression of ITGA5 and the corresponding clinicopathological parameters of LSCC patients the TCGA database. Five datasets (GSE51...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chongchang, Shen, Yiming, Wei, Zhengyu, Shen, Zhisen, Tang, Ming, Shen, Yi, Deng, Hongxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841133/ https://www.ncbi.nlm.nih.gov/pubmed/34994984 http://dx.doi.org/10.1002/jcla.24228

Ejemplares similares

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

tRNA(Ini) (CAT) inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells
por: Li, Jun, et al.
Publicado: (2021)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2018)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker
por: Shen, Zhisen, et al.
Publicado: (2020)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
por: Shen, Zhisen, et al.
Publicado: (2014)

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males
por: Shen, Zhisen, et al.
Publicado: (2016)

Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis
por: Shen, Zhisen, et al.
Publicado: (2018)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9
por: Lv, Yuan, et al.
Publicado: (2019)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020)

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
por: Gu, Shanshan, et al.
Publicado: (2023)

MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway
por: Ye, Dong, et al.
Publicado: (2019)

Expression of the long noncoding RNA RP11‐169D4.1‐001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance
por: Shen, Zhisen, et al.
Publicado: (2019)

Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer
por: Li, Jinyun, et al.
Publicado: (2020)

Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2
por: Li, Dapeng, et al.
Publicado: (2022)

SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Association between long-term exposure to air pollution and the risk of incident laryngeal cancer: a longitudinal UK Biobank-based study
por: Wang, Jiada, et al.
Publicado: (2023)

Zinc finger E-box binding homeobox 2 functions as an oncogene in human laryngeal squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Extranodal Extension as an Independent Prognostic factor in Laryngeal Squamous Cell Carcinoma Patients
por: Wang, Zhihai, et al.
Publicado: (2020)

Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma
por: Huang, Meixiang, et al.
Publicado: (2020)

Single-cell transcriptomic landscapes of a rare human laryngeal chondrosarcoma
por: Lin, Chen, et al.
Publicado: (2021)

Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma
por: Tu, Xiu-Ping, et al.
Publicado: (2015)

Identification of a prognostic 4-mRNA signature in laryngeal squamous cell carcinoma
por: Zhang, Cheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o8ebh8g2jgpdl3cvv7jr1kre0